Committed to sharing our science

393 results available

A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Shefner JM, Wolff AA, Meng L, Bian A, Lee J, Barragan D, Andrews JA, BENEFIT-ALS STUDY GROUP
August 17, 2016
CK-2127107, a Selective Activator of the Fast Skeletal Muscle Troponin Complex, for the Potential Treatment of Spinal Muscular Atrophy

Poster, 2016 MDA Clinical Conference
Arlington, VA
Rudnicki S, Andrews JA, Malik FI, Wolff AA, Day JW
March 2016
Decline in Slow Vital Capacity Predicts Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death

Poster, 2016 MDA Clinical Conference
Arlington, VA
Shefner JM, Meng L, Kulke SF, Rudnicki S, Wolff AA, Bozik ME, Malik FI, Andrews JA
March 2016
Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices of Treatment for a Year in ALS (VITALITY-ALS): Study Design of a Phase III Clinical Trial of Tirasemtiv in ALS

Poster, 2016 MDA Clinical Conference
Arlington, VA
Andrews JA, Wolff AA, Lee J, Barragan D, Meng L, Bian A, Malik FI, Shefner JM
March 2016
Decline in Slow Vital Capacity Predicts Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy or Death

Poster, 6th Annual California ALS Research Summit
La Jolla, CA
Andrews, JA, Meng L, Kulke SF, Rudnicki S, Wolff AA, Bozik ME, Malik FI, Shefner JM
January 2016